100 Patients enrolled in RADIAL!!

Utrecht, June 17, 2024

This month we reached the end of the recruitment phase in the RADIAL study and have enrolled over 100 patients. RADIAL is the proof-of-concept study conducted as part of Trials@Home

The trial is designed to compare a completely decentralized approach (home-based) with both traditional approach (site-based) and a hybrid approach incorporating several decentralized elements. This study involves participants living with type II diabetes and aims to innovate and understand the challenges associated with the decentralization of clinical trials.

Key aspects of this methodological study include eConsent, home nursing, technological innovations, central lab processes (including patient-drawn blood samples), a comprehensive study app, a central pharmacy that ships medication directly to participants, telehealth, and remote recruitment. The decentralization of clinical trials has the potential benefit to allow patients to conduct parts of the trial from home and collect data that closely resembles real-world conditions. Decentralized clinical trials can be crucial for increasing patient accessibility and engagement, ultimately leading to more inclusive and efficient research.

Want to know more about the RADIAL study? Visit https://trialsathome.com/about-radial/


This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234